Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

The Australian Polygenic Risk Symposium Sydney, 2019

Home All news & events Events The Australian Polygenic Risk Symposium…

When  18-19 November 2019

Time    12pm 18th November – 5pm 19th November

Where  Garvan Institute of Medical Research

Contact  Please email Melissa Vincent on prs@garvan.org.au

Contact   Register now through Eventbrite

Students: AUD $100 (excl. GST and booking fee)
Regular: AUD $200 (excl. GST and booking fee)

* Admission fee includes access to all sessions, a ticket to the social function on Monday 18 November and catering during the symposium

Abstract submissions open until 16 September, 2019

See the guidelines and dates and access the submission form.


Event information

The inaugural Australian Polygenic Risk Symposium will be a 1.5 day meeting from 18-19 November 2019 at the Garvan Institute of Medical Research in Sydney. It will bring together researchers, clinicians, educators and industry to focus on the applications of polygenic risk and its clinical implementation.